GLP-1 Agonists place in therapy

Discuss GLP-1 Agonists place in therapy (1 ½ page) Part2: Studies/trials on GLP-1 agonists Instructions a) Discussion on results from the DURATION trials (1,5,6 etc) (1 ½ pages) (discuss DURATION only) b) Make tables to compare results of DURATION trials, LEAD, Getgoal, HARMONY, AWARD, SCALE, Head-to-head (both tables on one page) (1 page) Example of table Table 1???????? Study Name Treatment agents Duration Inclusion Criterial Primary endpoint Authors/year DURATION Author/year e.g. Exenatide once per weekly or twice daily ≥16 years of age Change in HbA1c LEAD Getgoal HARMONY AWARD SCALE Head-to Head Table 2 summaries of studies Authors /year Type of study participants Intervention Design/Group results strengths Limitations e.g. RCT Part 3 Note: instructions Look at the evidence for the potential cardiovascular benefits of DPP4 inhibitors (6 pages to include introduction, the body and conclusion) to include: 1) Description of agents in this class (DPP4) 2)Discuss Potential cardiovascular benefits of agents in detail 3)Discussion on studies/clinical trials and results in detail 4) Make a table comparing results (please include authors/year in the table, and provide references for each author including those in the tables